Malaria : Symptoms & Prevention

Malaria : Symptoms & Prevention

Malaria : The Parasite Plasmodium is what causes Malaria, an infectious illness spread by mosquitoes. It spreads to people when infected female Anopheles mosquitoes bite people. Malaria is a significant global health problem, particularly in tropical and subtropical regions of the world, such as Africa, Asia, and Latin America.

Symptoms of Malaria typically include fever, chills, headache, muscle aches, fatigue, nausea, and vomiting. In severe cases, it can cause complications such as organ failure, anemia, and even death if left untreated. Malaria can affect people of all ages but is particularly dangerous for young children, pregnant women, and individuals with weakened immune systems.

Prevention and control of Malaria involve several strategies, including the use of insecticide-treated bed nets to protect against mosquito bites, indoor residual spraying with insecticides, and antimalarial drugs for both prevention and treatment. There are various medications available to treat Malaria, and the choice of drug depends on the type of Malaria parasite and its resistance patterns in a particular region.

Efforts to combat Malaria have made significant progress in recent years, resulting in a decline in Malaria cases and deaths globally. However, challenges such as drug resistance, insecticide resistance, and limited access to healthcare services in some regions still exist. Ongoing research and public health interventions are crucial to further reduce the burden of Malaria and work towards its eventual eradication.

Malaria Parasites

Plasmodium parasites are the primary cause of Malaria. There are five Plasmodium species that may infect people:

1. Plasmodium falciparum (P. falciparum):

  • P. falciparum is the most common and deadliest species of Malaria parasite.
  • It is responsible for the majority of severe Malaria cases and deaths.
  • This species is prevalent in sub-Saharan Africa, but it can also be found in other regions with Malaria transmission.

2. Plasmodium vivax (P. vivax):

  • P. vivax is the second most common species and has a broader geographical distribution.
  • It is found in Asia, Latin America, and parts of Africa.
  • P. vivax infections can cause recurring episodes of Malaria due to the parasite’s ability to remain dormant in the liver.

3. Plasmodium Malaria (P. Malaria):

  • P. Malariae is less common than P. falciparum and P. vivax.
  • It is distributed worldwide, but its prevalence is higher in Africa.
  • P. Malariae infections tend to have a milder course and longer intervals between symptomatic episodes.

4. Plasmodium ovale (P. ovale):

  • P. ovale is less common than P. falciparum and P. vivax.
  • It is primarily found in West Africa, although cases have been reported in other regions.
  • Like P. vivax, P. ovale infections can cause relapses due to dormant liver stages.

5. Plasmodium knowlesi (P. knowlesi):

  • P. knowlesi primarily infects monkeys but can also infect humans.
  • It is mainly found in Southeast Asia, particularly in Malaysia and parts of Indonesia.
  • P. knowlesi infections can cause severe Malaria in humans.

Each Plasmodium species has a complex life cycle involving both humans and female Anopheles mosquitoes. The parasite undergoes different developmental stages, including the liver stage (exogenous phase) and the blood stage (endogenous phase), within the human host. Mosquitoes become infected when they feed on a person with Malaria, and they subsequently transmit the parasites to other individuals through their bites.

Understanding the different Plasmodium species is crucial for effective diagnosis, treatment, and prevention strategies as each species has specific characteristics and may respond differently to Antimalarial drugs.

Transmission of Malaria

The main method of spreading Malaria is via the bites of female Anopheles mosquitoes that are infected. When a mosquito bites a person infected with Malaria, it ingests the Malaria parasites along with the blood. Inside the mosquito, the parasites undergo development and multiplication, eventually reaching the salivary glands of the mosquito. When the infected mosquito bites another person, it injects the parasites into their bloodstream, initiating a new infection cycle.

Vector Control Strategies:

Controlling the Mosquito vector is a key approach to Preventing Malaria Transmission. Several Strategies are employed to reduce Mosquito populations and Minimize the risk of infection:

1. Insecticide-Treated Bed Nets (ITNs):

    • ITNs are Long-lasting Insecticide-treated nets placed over sleeping areas to create a physical barrier against Mosquitoes.
    • The Insecticide on the nets repels and kills Mosquitoes upon contact, Reducing their biting and Transmitting Capacity.
    • ITNs are particularly effective in protecting vulnerable groups such as young children and pregnant women.

    2. Indoor Residual Spraying (IRS):

    • IRS Involves Spraying the Interior walls of houses with Insecticides that repel or kill Mosquitoes.
    • The Insecticides have a Residual effect, remaining effective for several months.
    • IRS can significantly reduce the Mosquito population, Interrupting Malaria Transmission in Targeted areas.

    3. Environmental Management:

    • Modifying the environment to Minimize Mosquito breeding sites is an Essential Component of Malaria control.
    • Removing Stagnant water sources, Improving Drainage systems, and proper waste management help Eliminate Mosquito breeding grounds.
    • This strategy aims to reduce the number of Mosquitoes and Minimize the risk of Malaria Transmission.

    4. Personal Protective Measures:

    • Individuals can protect themselves from Mosquito bites by wearing Long-sleeved clothing, using insect Repellents, and Avoiding outdoor activities during peak Mosquito biting hours (Typically dusk to dawn).
    • Personal Protective measures are especially important in areas with high Mosquito populations and Malaria Transmission.

    5. Vector Surveillance and Monitoring:

    • Regular monitoring of Mosquito populations and their Susceptibility to Insecticides helps identify areas of high transmission and potential insecticide resistance.
    • Surveillance data informs targeted interventions and helps Evaluate the Effectiveness of control measures.

    It’s important to note that vector control measures are most effective when used in combination with other Strategies such as prompt Diagnosis and treatment of Malaria cases, access to Antimalarial drugs, and health education to promote Awareness and behavior change in affected Communities. Integrated Approaches Tailored to specific regions and local conditions have proven to be successful in Reducing Malaria Transmission.

    Clinical Presentation and Symptoms of Malaria

    The symptoms of Malaria can vary Depending on the species of the Malaria Parasite, the Individual’s immune response, and other factors. The onset and Severity of symptoms can also differ between Uncomplicated and severe Malaria cases. Here are the key aspects of the Clinical Presentation of Malaria:

    1. Common Symptoms:

    • Fever is the Hallmark symptom of Malaria and is often Accompanied by chills and rigor (Shivering).
    • Headache, body aches, and muscle pain are Frequently reported.
    • Fatigue, weakness, and malaise are common during the acute phase of the infection.
    • Nausea, Vomiting, and Diarrhea may occur, particularly in children.

    2. Fever Pattern:

    • Malaria Typically presents with Intermittent fever that occurs in cycles, Depending on the Parasite species involved.
    • In P. Falciparum Malaria, fever episodes are Irregular, with high fever spikes followed by periods of normal or slightly Decreased temperature.
    • P. vivax and P. ovale Malaria may exhibit a fever pattern with Recurrent episodes every 48 hours (tertian fever) or every 72 hours (quartan fever).

    3. Uncomplicated Malaria:

    • Uncomplicated Malaria refers to cases where the infection has not caused severe complications or organ dysfunction.
    • In addition to fever, other symptoms may include headache, body aches, fatigue, nausea, and sweating.
    • Symptoms can vary in intensity, and individuals may experience recurrent fever episodes if not promptly treated.

    4. Severe Malaria:

    • Severe Malaria is a life-threatening condition and requires urgent medical attention.
    • Symptoms of severe Malaria include high fever, severe headache, confusion, altered consciousness, seizures, and coma.
    • Other signs may include jaundice (yellowing of the skin and eyes), severe anemia, respiratory distress, kidney failure, and cardiovascular complications.

    5. Specific Symptoms in Different Age Groups:

    • Children are more susceptible to severe Malaria, and symptoms in pediatric cases may manifest as severe anemia, respiratory distress, seizures, and impaired consciousness.
    • Pregnant women with Mosquito-borne disease may experience more severe symptoms and are at an increased risk of complications such as maternal anemia, spontaneous abortion, stillbirth, and low birth weight in newborns.

    It’s important to note that the clinical presentation of Mosquito-borne disease can overlap with other febrile illnesses. Proper diagnosis through laboratory testing, such as blood smears or rapid diagnostic tests, is necessary to confirm a Mosquito-borne disease infection and identify the specific parasite species. Prompt diagnosis and effective treatment are crucial to prevent complications and reduce the risk of severe Malaria.

    Also Read – Monkeypox (Mpox) : Overview & Diagnosis

    Diagnosis and Laboratory Testing of Malaria

    Accurate diagnosis of Malaria is essential to ensure appropriate treatment and prevent complications. Laboratory testing is the primary method used to confirm the presence of Mosquito-borne disease parasites and identify the species involved. Here are the main diagnostic methods used for Malaria:

    A. Microscopic Examination of Blood Smears:

    • Microscopic examination of thick and thin blood smears is the gold standard for Mosquito-borne disease diagnosis.
    • A drop of blood is smeared on a microscope slide, stained, and examined under a microscope.
    • This technique allows for the identification and quantification of Mosquito-borne disease parasites and determination of the parasite species.

    B. Rapid Diagnostic Tests (RDTs):

    • RDTs are point-of-care diagnostic tools that provide rapid results within 15 to 20 minutes.
    • They detect specific Mosquito-borne disease antigens (usually histidine-rich protein 2 or lactate dehydrogenase) in a blood sample.
    • RDTs are easy to use, do not require special equipment, and can be performed in resource-limited settings.
    • However, they have limitations, such as reduced sensitivity in low-level parasitemia and potential variability in performance between different RDT brands.

    C. Molecular Methods:

    • Polymerase chain reaction (PCR) is a highly sensitive and specific molecular technique used for Malaria diagnosis and species identification.
    • PCR-based methods detect and amplify Malaria DNA/RNA in the patient’s blood.
    • These methods can detect very low levels of parasitemia and differentiate between different species of Mosquito-borne disease parasites.
    • PCR is often used in research settings, reference laboratories, or when there is a need for accurate species identification.

    It is important to note that laboratory testing should be performed by trained personnel in well-equipped laboratories. In areas with limited access to laboratory facilities, RDTs are valuable tools for initial screening and prompt treatment initiation. If RDT results are positive or there is a high suspicion of Malaria, confirmatory testing with microscopic examination of blood smears is recommended.

    Clinical suspicion, epidemiological context, and patient travel history are also considered when making a Malaria diagnosis. False-negative or false-positive results can occur with any diagnostic method, so the overall clinical picture should be taken into account when interpreting test results.

    Early and accurate diagnosis is crucial for prompt treatment initiation, especially in cases of severe Malaria, and helps prevent the Progression of the disease and potential Complications.

    Treatment of Malaria

    The treatment of Mosquito-borne disease aims to clear the Malaria Parasites from the Patient’s Bloodstream, Alleviate symptoms, prevent Complications, and reduce Transmission. The choice of treatment depends on several factors, including the Mosquito-borne disease Parasite species, the Severity of the infection, the age and health status of the patient, and the drug resistance patterns in the specific region. Here are the main aspects of Mosquito-borne disease treatment:

    1. Antimalarial Medications:

    • Artemisinin-based combination Therapies (ACTs) are the Recommended First-line treatment for Uncomplicated Mosquito-borne disease caused by Plasmodium Falciparum, the most common and deadly Malaria Parasite.
    • ACTs combine an Artemisinin Derivative (such as artemether or artesunate) with a partner drug (such as lumefantrine or mefloquine).
    • ACTs are highly effective in rapidly Reducing the Parasite load and curing the infection.
    • Other Antimalarial drugs, such as Chloroquine, quinine, Doxycycline, and Atovaquone-proguanil, may be used as alternative or Adjunctive treatments Depending on the Parasite species and drug resistance patterns.

    2. Treatment of Severe Malaria:

    • A hospital setting is necessary for the immediate and vigorous treatment of severe Malaria.
    • In many areas, intravenous (IV) artesunate is the preferred therapy for severe P. falciparum Malaria.
    • Quinine, administered intravenously or orally, is an alternative for areas where artesunate is not available.
    • Supportive care, including fluid resuscitation, management of complications, and close monitoring, is crucial in severe Mosquito-borne disease cases.

    3. Pregnant Women and Children:

    • Pregnant women with Malaria require special Consideration due to potential risks to both the mother and fetus.
    • Antimalarial drugs, such as Chloroquine or a combination of Sulfadoxine-pyrimethamine and Azithromycin, may be used for pregnant women, Depending on the region and drug resistance patterns.
    • For infants and young children, appropriate dosing of Antimalarial medications based on their weight is important to ensure Efficacy and Minimize adverse effects.

    4. Drug Resistance and Regional Guidelines:

    • Drug resistance is a significant challenge in Malaria treatment, particularly with P. Falciparum.
    • Regional Guidelines and Protocols, often Established by national Mosquito-borne disease control programs and the World Health Organization, provide specific Recommendations for Mosquito-borne disease treatment based on the local drug resistance patterns.
    • Regular monitoring of drug Efficacy and resistance helps guide treatment Strategies and informs updates to treatment Guidelines.

    It is crucial to complete the full course of Antimalarial treatment as Prescribed, even if symptoms improve before the treatment is finished. This helps prevent the development of drug resistance and ensures complete Eradication of the Malaria Parasites.

    Proper management of Malaria cases requires trained Healthcare professionals, access to Accurate Diagnosis, appropriate drug supply, and Supportive care. Early Diagnosis and prompt Initiation of treatment are Essential to prevent Complications and reduce Mortality Associated with severe Malaria.

    Preventive Measures for Malaria

    Prevention plays a vital role in Reducing the Incidence of Malaria. Various Strategies can be employed to prevent Malaria Transmission and protect individuals living in or traveling to areas with Malaria. Here are the key Preventive measures:

    A. Vector Control:

    • Insecticide-Treated Bed Nets (ITNs): Sleeping under ITNs provides a physical barrier against Mosquito bites. ITNs are effective in Reducing Malaria Transmission, particularly among vulnerable populations such as children and pregnant women.
    • Indoor Residual Spraying (IRS): Spraying Insecticides on the Interior walls of houses kills Mosquitoes and reduces their population.
    • Environmental Management: Eliminating Mosquito breeding sites by Promoting proper Drainage, Reducing Stagnant water, and Improving waste management helps control Mosquito populations.

    B. Chemoprophylaxis:

    • For individuals traveling to areas with a high risk of Mosquito-borne disease Transmission, taking Antimalarial medications as Chemoprophylaxis can prevent infection.
    • The choice of Chemoprophylactic drug depends on the Mosquito-borne disease Parasite species Prevalent in the Destination, as well as drug resistance patterns.
    • It is important to consult Healthcare professionals or travel medicine clinics for Personalized advice on appropriate Chemoprophylaxis.

    C. Personal Protection Measures:

    • Use of Insect Repellents: Applying insect Repellents containing DEET (N,N-diethyl-meta-toluamide), Picaridin, or other Approved Ingredients on exposed skin and clothing helps repel Mosquitoes.
    • Protective Clothing: Wearing Long-sleeved shirts, long pants, socks, and Closed-toe shoes reduces the amount of exposed skin Susceptible to Mosquito bites.
    • Avoidance of Peak Biting Hours: Mosquitoes that Transmit Malaria are most active during dusk and dawn. Avoiding outdoor activities during these times can Minimize Exposure.

    D. Malaria Vaccination:

    • The RTS,S/AS01 Malaria vaccine, also known as Mosquirix, has been developed for the Prevention of Mosquito-borne disease caused by P. Falciparum in young children.
    • The vaccine has Demonstrated partial Efficacy in Clinical trials and is currently being piloted in Selected regions of Sub-Saharan Africa.
    • Vaccination efforts are ongoing, and research continues to develop more effective Malaria Vaccines.

    E. Health Education and Community Engagement:

    • Raising Awareness about Malaria Prevention and control through Community-based education programs is Essential.
    • Educating individuals about the importance of using bed nets, seeking early Diagnosis and treatment, and Adopting Preventive measures Empowers Communities to take active roles in Malaria Prevention.

    It is important to note that Preventive measures are most effective when Implemented in combination, based on local Epidemiology, and Tailored to the specific needs of the community. Integrated Approaches that combine vector control, Chemoprophylaxis, and personal protection measures have proven to be effective in Reducing Mosquito-borne disease Transmission.

    Epidemiology and Global Efforts

    Mosquito-borne disease continues to pose a serious threat to world health, particularly in tropical and subtropical areas. Here are some key aspects of the epidemiology of Malaria:

    1. Global Burden:

    • The World Health Organization (WHO) estimates that there were 229 million cases of Mosquito-borne disease globally in 2019, resulting in around 409,000 fatalities from Mosquito-borne disease.
    • The burden of Mosquito-borne disease is highest in sub-Saharan Africa, where over 90% of Malaria cases and deaths occur, primarily affecting children under the age of five and pregnant women.
    • Other regions with a high Mosquito-borne disease burden include Southeast Asia, the Eastern Mediterranean, and the Western Pacific.

    2. Malaria-Endemic Countries:

    • Malaria is endemic in approximately 87 countries, primarily in Africa, Asia, and Latin America.
    • Some countries in sub-Saharan Africa, such as Nigeria, the Democratic Republic of the Congo, and Mozambique, bear a disproportionately high Malaria burden.
    • India and several countries in Southeast Asia also have a significant Malaria burden.

    3. Malaria Transmission Seasonality:

    • Malaria Transmission often Exhibits Seasonal patterns, Influenced by Climatic conditions, Mosquito populations, and human activities.
    • In many regions, Malaria Transmission increases during or after rainy seasons when Mosquito breeding sites Multiply.
    • Seasonal Variations in Transmission Intensity can impact the timing and Intensity of Malaria Outbreaks.

    4. Impact on Vulnerable Populations:

    • Malaria has the greatest impact on vulnerable populations, including young children, pregnant women, and individuals with Weakened immune systems.
    • Pregnant women are particularly Susceptible to severe Mosquito-borne disease and face Increased risks of Maternal anemia, Spontaneous Abortion, Stillbirth, and low birth weight in Newborns.

    Also Read – A Wart : Causes, Symptoms & Treatment Options

    Global Efforts to Combat Malaria

    Significant progress has been made in the fight against Mosquito-borne disease, thanks to global efforts and Collaborations. Here are key Initiatives and Strategies in place to combat Malaria:

    A. The Global Malaria Program (GMP):

    • The GMP, led by the World Health Organization (WHO), provides Strategic Guidance, Technical support, and Coordination for Malaria control and Elimination efforts worldwide.
    • The GMP Collaborates with partner organizations, national Mosquito-borne disease control programs, and other Stakeholders to Strengthen Mosquito-borne disease Prevention, Diagnosis, treatment, and surveillance.

    B. Roll Back Malaria Partnership (RBM):

    • The RBM Partnership is a global framework for coordinated action against Mosquito-borne disease, bringing together governments, organizations, and affected Communities.
    • RBM aims to Accelerate progress in Mosquito-borne disease control and Elimination by Advocating for Increased funding, Promoting Innovative Approaches, and Fostering Collaboration among partners.

    C. Malaria Elimination Initiatives:

    • Several countries and regions have set Ambitious goals to Eliminate Mosquito-borne disease within their borders.
    • The “Malaria-Free” Initiatives strive to interrupt local Mosquito-borne disease Transmission, reduce Malaria-related Morbidity and Mortality, and eventually Eliminate Mosquito-borne disease as a public Health problem.

    D. Research and Development:

    • Ongoing research efforts focus on Developing new tools, such as Improved Diagnostic tests, more effective drugs, and potential Malaria Vaccines.
    • Investments in research are crucial to address challenges like drug resistance, Insecticide resistance, and gaps in Prevention and treatment Strategies.

    E. Funding and International Support:

    • Financial resources for Mosquito-borne disease control and Elimination programs come from various sources, including governments, Multilateral organizations, Philanthropic foundations, and Partnerships.
    • Initiatives like the Global Fund to Fight AIDS, Tuberculosis, and Mosquito-borne disease play a significant role in Mobilizing resources to support Malaria programs in endemic countries.

    The global Community’s commitment to Mosquito-borne disease control and Elimination has Contributed to a Reduction in Mosquito-borne disease cases and deaths over the years. However, challenges such as drug resistance, Insecticide resistance, and limited access to Healthcare services in some regions Necessitate Sustained efforts and continued investments to achieve the goal of a Mosquito-borne disease-free world.

    Challenges and Future Directions in Malaria Control and Elimination

    While significant progress has been made in Combating Malaria, several challenges remain. Addressing these challenges and Adopting Innovative Strategies are crucial for future success. The following are some significant issues and Probable future directions:

    1. Drug Resistance:

    • Drug resistance, particularly in Plasmodium falciparum, poses a significant challenge to Malaria control.
    • Continued monitoring of drug efficacy and resistance patterns is essential to guide treatment strategies and ensure effective antimalarial drug use.
    • Developing and deploying new antimalarial drugs with different mechanisms of action is critical to combat drug resistance.

    2. Insecticide Resistance:

    • Mosquitoes that transmit Malaria have shown resistance to commonly used insecticides, compromising vector control efforts.
    • Integrated vector management approaches, including the use of alternative insecticides and new vector control tools, should be developed and implemented.
    • Research into novel strategies such as genetically modified mosquitoes and biological control methods may provide future solutions.

    3. Access to Healthcare and Diagnostic Services:

    • Limited access to Healthcare services, especially in remote and Resource-constrained areas, hinders early diagnosis and prompt treatment.
    • Strengthening Healthcare systems, Improving Diagnostic Capacity, and Expanding access to Affordable and Quality-assured Antimalarial drugs are crucial to reach affected Communities Effectively.

    4. Malaria in Fragile and Conflict-Affected Areas:

    • Malaria control efforts are particularly challenging in areas affected by conflicts, displacement, and weak governance.
    • Collaborative efforts involving humanitarian organizations, peacekeeping missions, and local communities are needed to address Mosquito-borne disease in these settings.
    • Strengthening surveillance and ensuring access to healthcare services in unstable environments can contribute to controlling Malaria transmission.

    5. Climate Change and Environmental Factors:

    • Climate change can affect the distribution and behavior of mosquitoes, altering Malaria transmission patterns.
    • Monitoring and adapting Malaria control strategies to changing climatic conditions are essential.
    • Environmental management, such as controlling mosquito breeding sites and improving water resource management, can help mitigate the impact of climate change on Malaria transmission.

    6. Vaccine Development:

    • The development of an effective Malaria vaccine remains a priority in Mosquito-borne disease research.
    • Continued efforts to improve existing vaccine candidates, such as the RTS,S/AS01 vaccine, and explore new vaccine targets and delivery methods are crucial.
    • Vaccine development may provide a powerful tool for Mosquito-borne disease prevention and control, particularly in combination with other preventive measures.

    7. Community Engagement and Behavior Change:

    • Community participation, awareness, and behavior change play vital roles in Mosquito-borne disease control.
    • Effective health education campaigns, community engagement, and involvement of local leaders can improve prevention practices and adherence to treatment.
    • Empowering communities to take ownership of Mosquito-borne disease control efforts can contribute to sustainable progress.

    Addressing these challenges requires sustained political commitment, increased funding, and collaboration among governments, organizations, researchers, and affected communities. By adopting integrated and innovative approaches, improving access to healthcare services, and investing in research and development, it is possible to make further strides towards the goal of Malaria elimination and eventual eradication.


    Malaria is a significant global health challenge, particularly in regions with a high Mosquito-borne disease burden such as sub-Saharan Africa, Asia, and Latin America. It is caused by parasites of the Plasmodium genus and transmitted through the bites of infected mosquitoes. Mosquito-borne disease can lead to severe complications and even death if left untreated, making prevention, diagnosis, and treatment crucial.

    Efforts to combat Mosquito-borne disease have resulted in substantial progress over the years. Global initiatives, such as the Global Mosquito-borne disease Program and the Roll Back Malaria Partnership, have played vital roles in coordinating and supporting Mosquito-borne disease control and elimination efforts. These initiatives focus on strategies like vector control, early diagnosis, prompt treatment, preventive measures, and community engagement.

    However, challenges remain, including drug resistance, insecticide resistance, limited access to healthcare services, and climate change impacts. Addressing these challenges requires ongoing research, innovative approaches, and strengthened healthcare systems. Investing in the development of new antiMalarial drugs, vaccines, and vector control tools is essential.

    The future direction of Malaria control and elimination should focus on sustainable approaches tailored to specific regions, leveraging technological advancements, and engaging communities. By strengthening healthcare systems, improving access to diagnostics and treatment, and promoting preventive measures, we can work towards reducing the burden of Mosquito-borne disease and ultimately achieving a Malaria-free world.

    Individuals, communities, governments, researchers, and organizations must continue to collaborate and prioritize Mosquito-borne disease control efforts. With sustained commitment and coordinated action, we can make significant progress in overcoming the challenges and move closer to the ultimate goal of eradicating Mosquito-borne disease as a major public health threat.


    The information on this website is provided for Informational reasons and is not meant to be personal medical advice. You should consult your doctor or another Qualified fitness professional if you have any concerns about a Systemic condition. Never Disregard professional medical advice or give up looking for it because of something you read on this website. The does not promote or recommend any products.

    Also Read – Monsoon Season: Illnesses & Health Risks

    Leave a Reply

    Your email address will not be published. Required fields are marked *